Transvenous implantable cardioverter-defibrillator leads: The weakest link

Circulation

Volumn 115, Issue 19, 2007, Pages 2461-2463

  Maisel, William H ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Death, sudden; Defects; Defibrillation; Editorials; Tachyarrhythmias

Indexed keywords

ARTIFICIAL HEART PACEMAKER; COURSE EVALUATION; DEFIBRILLATOR; DEVICE REMOVAL; DISEASE REGISTRY; EDITORIAL; FOLLOW UP; HEART VENTRICLE ARRHYTHMIA; HUMAN; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; SURVIVAL RATE;

COST-BENEFIT ANALYSIS; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; DEVICE REMOVAL; ELECTRODES, IMPLANTED; EQUIPMENT DESIGN; EQUIPMENT FAILURE; FOLLOW-UP STUDIES; HUMANS; SUBCLAVIAN VEIN; VENTRICULAR FIBRILLATION;

EID: 34248530016     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.107.698597     Document Type: Editorial

References (19)

1. Maisel WH, Moynahan M, Zuckerman BD, Gross TP, Tovar OH, Tillman DB, Schultz DB. Pacemaker and ICD generator malfunctions: analysis of Food and Drug Administration annual reports. JAMA. 2006;295:1901-1906.
2. Anvari A, Stix G, Grabenwoger M, Schneider B, Turel Z, Schmidinger H. Comparison of three cardioverter defibrillator implantation techniques: initial results with transvenous pectoral implantation. Pacing Clin Electrophysiol. 1996;19:1061-1069.
3. Maisel WH. Pacemaker and ICD generator reliability: meta-analysis of device registries. JAMA. 2006;295:1929-1934.
4. Maisel WH. Safety issues involving medical devices: implications of recent implantable cardioverter-defibrillator malfunctions. JAMA. 2005;294:955-958.
5. Maisel WH. Increased failure rate of a polyurethane ICD lead. Pacing Clin Electrophysiol. 2002;25:877-878.
6. Pratt TRH, Pulling CC, Stanton MS. Prospective device studies versus returned product analysis as a predictor of system survival. Pacing Clin Electrophysiol. 2000;23:1150-1155.
7. Maloney JD, Hayes DL, Timmis GC. Report of the Policy Conference of NASPE on device/lead performance and the development of a postmarket surveillance database. The Writing Committee. Pacing Clin Electrophysiol. 1993;16:1945-1952.
8. Kleeman T, Becker T, Doenges K, Vater M, Senges J, Schneider S, Saggau W, Weisse U, Seidl K. Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years. Circulation. 2007;115:2474-2480.
9. Kron J, Herre J, Renfroe EG, Rizo-Patron C, Raitt M, Halperin B, Gold M, Goldner B, Wathen M, Wilkoff B, Olarte A, Yao Q. Lead- and device-related complications in the Antiarhrythmics Versus Implantable Defibrillators trial. Am Heart J. 2001;141:92-98.
10. Hauser RG, Cannom D, Hayes DL, Parsonnet V, Hayes J, Ratliff N III, Tyers GFO, Epstein AE, Vlay SC, Furman S, Gross J. Long-term structural failure of coaxial polyurethane implantable cardioverter defibrillator leads. Pacing Clin Electrophysiol. 2002;25:879-882.
11. Luria D, Glikson M, Brady PA, Lexvold NY, Rasmussen MJ, Hodge DO, Chugh SS, Rea RF, Hayes DL, Hammill SC, Friedman PA. Predictors and mode of detection of transvenous lead malfunction in implantable defibrillators. Am J Cardiol. 2001;87:901-904.
12. Dorwarth U, Frey B, Dugas M, Matis T, Fiek M, Schmoeckel M, Remp T, Durchlaub I, Gerth A, Steinbeck G, Hoffman E. Transvenous defibrillation leads: high incidence of failure during long-term follow-up. J Cardiovasc Electrophysiol. 2003;14:38-43.
13. Hauser R, Hayes D, Parsonnet V, Furman S, Epstein A, Hayes J, Saksena S, Irwin M, Almquist A, Cannom D, Gross J, Kallinen L. Feasibility and initial results of an Internet-based pacemaker and ICD pulse generator and lead registry. Pacing Clin Electrophysiol. 2001;24:82-87.
14. Ellenbogen KA, Wood MA, Shepard RK, Clemo HF, Vaughn T, Holloman K, Dow M, Leffler J, Abeyratne A, Verness D. Detection and management of an implantable cardioverter defibrillator lead failure: incidence and clinical implications. J Am Coll Cardiol. 2003;41:73-80.
15. Gunderson BD, Gillberg JM, Wood MA, Vijayaraman P, Shepard RK, Ellenbogen KA. Development and testing of an algorithm to detect implantable cardioverter-defibrillator lead failure. Heart Rhythm. 2006;3:155-162.
16. Mark DB, Nelson CL, Anstrom KJ, Al-Khatib SM, Tsiatis AA, Cowper PA, Clapp-Channing NE, Davidson-Ray L, Poole JE, Johnson G, Anderson J, Lee KL, Bardy GH; SCD-HeFT Investigators. Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Circulation. 2006;114:135-142.
17. Medtronic cardiac rhythm disease management product performance report: important patient management information for physicians. Available at: http://www.medtronic.com/crm/performance/downloads/ mdt_prod_performance_2006_2_en_online.pdf. Accessed March 23, 2007.
18. St. Jude Medical. Product performance report: cardiac rhythm management: October 2006. Available at: http://www.sjm.com/documents/ppr.pdf. Accessed March 23, 2007.
19. Boston Scientific. CRM product performance report 2007. Available at: http://www.guidant.com/ppr/ppr_archives/2007/Q1_PPR.pdf. Accessed March 23, 2007.